Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

Authors:

Abstract
No abstract available

This publication has 12 references indexed in Scilit: